Ameritas Investment Partners, Inc. Macrogenics Inc Transaction History
Ameritas Investment Partners, Inc.
- $2.86 Billion
- Q1 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Macrogenics Inc stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 6,300 shares of MGNX stock, worth $25,829. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,300
Previous 6,300
-0.0%
Holding current value
$25,829
Previous $60,000
53.33%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding MGNX
# of Institutions
170Shares Held
62.5MCall Options Held
819KPut Options Held
79.4K-
Bellevue Group Ag Kuesnacht, V89.97MShares$40.9 Million2.3% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.15MShares$25.2 Million1.09% of portfolio
-
Black Rock Inc. New York, NY5.7MShares$23.4 Million0.0% of portfolio
-
State Street Corp Boston, MA4.39MShares$18 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.68MShares$15.1 Million0.0% of portfolio
About MACROGENICS INC
- Ticker MGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,458,800
- Market Cap $252M
- Description
- MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...